Status:
COMPLETED
Obesity, Sleep Apnea, and Insulin Resistance
Lead Sponsor:
Stanford University
Conditions:
Insulin Sensitivity
Obstructive Sleep Apnea
Eligibility:
All Genders
30-70 years
Phase:
NA
Brief Summary
Obstructive sleep apnea (OSA) and type 2 diabetes confer increasing economic, social, and public health burdens in the United States. That these diseases appear to co-exist and together increase one's...
Eligibility Criteria
Inclusion
- Healthy Individuals
- Age 30-70 years old
- BMI- 25-40 kg/m2
- Must meet criteria for obstructive sleep apnea by overnight in-laboratory polysomnography
Exclusion
- Any significant co-morbidities, such as diabetes, active heart, kidney, liver diseases, or active or history of bladder cancer.
- Must not have previously received treatment for OSA, including CPAP.
- Must not be receiving any medications intended for weight loss, or those known to influence insulin sensitivity.
- Pregnancy/lactation is also an exclusion.
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT02192684
Start Date
September 1 2010
End Date
March 1 2015
Last Update
April 21 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.